PRDX2 and cancer: In addition, critically, the present study identified transcriptional activation of PRDX2 by SNAI1, a zinc‐finger transcription factor that transcriptionally represses or transcriptionally activates the expression of target genes and is a driver of cancer progression, including cell invasion, survival, stem cell properties, and metabolic regulation [23].